We have taken a simple translational approach to improve anti-inflammatory antibodies in animal disease models by conferring collagen binding affinity to the antibodies. This material relates to a ...

is building on these insights and pursuing the next breakthrough in treating vascular disease with ATH3G10. The monoclonal antibody ATH3G10 is a first-in-class antibody to target phosphorylcholine ...